CBD Life Sciences Inc.
CBDL
$0.0004
$0.000.00%
| 03/31/2024 | 03/31/2023 | 03/31/2022 | 09/30/2021 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -83.33% | -99.94% | -- | 25,565.00% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | 114.42% | |
| Prepaid Expenses | -- | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | 4,123.23% | |
|
|
|||||
| Total Current Assets | -- | -- | -- | 4,123.23% | |
| Net Property, Plant & Equipment | -- | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | 0.00% | |
| Goodwill | -- | -- | -- | 0.00% | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -59.17% | |
| Total Assets | -- | -- | -- | 892.29% | |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | |
| Total Accrued Expenses | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | |
|
|
|||||
| Total Current Liabilities | -- | -- | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -76.97% | |
| Total Liabilities | -- | -- | -- | -79.71% | |
|
|
|||||
| Common Stock & APIC | -- | -- | -- | 105.33% | |
| Retained Earnings | -- | -- | -- | -85.85% | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 303.65% | -94.60% | -- | 1,715.94% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | 0.00% | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 0.00% | 0.00% | -- | 0.00% | |
|
|
|||||
| Total Common Equity | 303.65% | -94.60% | -- | 1,715.94% | |
| Total Preferred Equity | 0.00% | 0.00% | -- | 0.00% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 154.42% | -89.91% | -- | 10,937.40% | |
|
|
|||||
